Elucigene CF4v2 Kits
The Elucigene CF4v2 kit is specifically designed for cystic fibrosis neonatal screening programs. It is developed to meet the requirements of the newborn screening program recently introduced into England and Wales. The Elucignene CF4v2 product is a fluorescent ARMS assay that detects the four most common CFTR mutations in the UK population.
Key Benefits of using Elucigene CF4v2 kit:
- A full genotyping assay in a single tube
- Rapid and simple detection of the four most frequent CFTR mutations in a UK Caucasian population
- Optimised for use with DNA extracted from dried bloodstains. Mutations detected by this assay are F508del, G551D, G542X and 621+1G>T.
This product is not approved by the FDA and is not available for sale in the US
| Description | Quantity | Catalogue |
|---|---|---|
| Elucigene CF4v2 specifically designed for cystic fibrosis newborn screening programs in England and Wales. Detects the four most common Cystic Fibrosis mutations: F508del, G551D, G542X and 621+1G>T. |
25 test kit | CF4HTB1 |
| Cat # | Product | Kit Size | Instructions for Use |
|---|---|---|---|
| CF4HTB1 | Elucigene CF4v2 | 25 tests | EN |
GeneMapper analysis files & settings:
| GeneMapper 3.7 and above |
| GeneMapper settings |
GENEMAPPER is a trademark of Applied Biosystems, LLC.
| Cat # | Product | Kit Size | MSDS |
|---|---|---|---|
| CF4HTB1 | ELUCIGENE CF4v2 | 25 tests | EN |
The Elucigene CF4v2 kit complies with the EC Directive 98/79/EC, carries the CE mark and is manufactured within quality systems accredited to ISO9001:2008 and ISO13485:2003. Full technical support is provided to purchasers of kits to ensure acceptable performance and customer satisfaction.
This product is not approved by the FDA and is not available for sale in the US
For additional availability in other countries please contact your local sales rep or distributor.